NEW YORK (GenomeWeb) – MDxHealth today announced a scientific agreement with the commercialization arm of the Queensland University of Technology, QUT bluebox, to develop a liquid biopsy epigenetic assay for the early detection of oral cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.